En español
NIDA

International Forum Scientific Exchange

InWomen's Group

 

NOTE: The deadline for poster abstracts and travel award applications has been extended to January 13, 2012.

June 11–15, 2010
Scottsdale, Arizona

The Red Latinamericano de Investigaciones en Drogas (known commonly as REDLA) is making an impact on the sphere of drug abuse and addiction research in Latin America.

A network of academic researchers who share an interest in developing research on the drug problem in Latin America, REDLA is a joint effort between NIDA and the Organization of American States, through their Inter-American Drug Control Commission (CICAD), with the collaboration of the National Hispanic Science Network on Drug Abuse.

The NIDA International Program supported the participation of scientists from Argentina, Peru, and South Africa at the 2nd International HIV Treatment as Prevention Workshop, which was held April 22–25, 2012, in Vancouver, Canada. The meeting was organized by Julio S.G. Montaner, M.D., University of British Columbia, and featured a keynote address by U.S. Global AIDS Coordinator Ambassador Eric Goosby about the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) perspective on treatment as prevention.

The NIDA International Program has supported researchers who participated in three recent scientific meetings:

If you would like to view these presentations, you may click on any of the links below to request a copy via email.

If you would like to view these presentations, you may click the links below to request a copy via email.

The Society for Prevention Research (SPR) recently welcomed scientists and experts from around the world to explore prevention science from a global health perspective with the intent of fostering worldwide rapid development of evidence-based policies, strategies, and programs.

As part of an ongoing initiative to accelerate research findings into use by substance abuse treatment providers, NIDA hosted its Blending Initiative Conference in Atlanta on April 19, 2012, in conjunction with the American Society of Addiction Medicine (ASAM) 43rd Medical-Scientific Conference.

Pages